| Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial PB Gilbert, DC Montefiori, AB McDermott, Y Fong, D Benkeser, W Deng, ... Science 375 (6576), 43-50, 2022 | 957 | 2022 |
| Randomized, double-blind, placebo-controlled study of brodalumab, a human anti–IL-17 receptor monoclonal antibody, in moderate to severe asthma WW Busse, S Holgate, E Kerwin, Y Chon, JY Feng, J Lin, SL Lin American journal of respiratory and critical care medicine 188 (11), 1294-1302, 2013 | 719 | 2013 |
| A randomized, double-blind, placebo-controlled study of tumor necrosis factor-α blockade in severe persistent asthma SE Wenzel, PJ Barnes, ER Bleecker, J Bousquet, W Busse, SE Dahlén, ... American journal of respiratory and critical care medicine 179 (7), 549-558, 2009 | 565 | 2009 |
| Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial JK Han, C Bachert, W Fokkens, M Desrosiers, M Wagenmann, SE Lee, ... The Lancet Respiratory Medicine 9 (10), 1141-1153, 2021 | 366 | 2021 |
| Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast HS Nelson, WW Busse, E Kerwin, N Church, A Emmett, K Rickard, ... Journal of allergy and clinical immunology 106 (6), 1088-1095, 2000 | 346 | 2000 |
| Efficacy and safety of NVA237 versus placebo and tiotropium in patients with COPD: the GLOW2 study E Kerwin, J Hébert, N Gallagher, C Martin, T Overend, VKT Alagappan, ... European Respiratory Journal 40 (5), 1106-1114, 2012 | 320 | 2012 |
| Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary … M Decramer, A Anzueto, E Kerwin, T Kaelin, N Richard, G Crater, ... The Lancet Respiratory Medicine 2 (6), 472-486, 2014 | 308 | 2014 |
| Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study AD D’Urzo, SI Rennard, EM Kerwin, V Mergel, AR Leselbaum, ... Respiratory research 15, 1-18, 2014 | 200 | 2014 |
| Efficacy and safety of a 12-week treatment with twice-daily aclidinium bromide in COPD patients (ACCORD COPD I) EM Kerwin, AD D'Urzo, AF Gelb, H Lakkis, EG Gil, CF Caracta COPD: Journal of Chronic Obstructive Pulmonary Disease 9 (2), 90-101, 2012 | 198 | 2012 |
| Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised … LA Lee, Z Bailes, N Barnes, LP Boulet, D Edwards, A Fowler, NA Hanania, ... The Lancet Respiratory Medicine 9 (1), 69-84, 2021 | 181 | 2021 |
| FLIGHT1 and FLIGHT2: efficacy and safety of QVA149 (indacaterol/glycopyrrolate) versus its monocomponents and placebo in patients with chronic obstructive pulmonary disease DA Mahler, E Kerwin, T Ayers, A FowlerTaylor, S Maitra, C Thach, M Lloyd, ... American journal of respiratory and critical care medicine 192 (9), 1068-1079, 2015 | 180 | 2015 |
| Indacaterol once-daily provides superior efficacy to salmeterol twice-daily in COPD: a 12-week study S Korn, E Kerwin, S Atis, C Amos, R Owen, C Lassen, ... Respiratory medicine 105 (5), 719-726, 2011 | 152 | 2011 |
| Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial GT Ferguson, JM FitzGerald, ER Bleecker, M Laviolette, D Bernstein, ... The Lancet Respiratory Medicine 5 (7), 568-576, 2017 | 118 | 2017 |
| Efficacy of umeclidinium/vilanterol versus umeclidinium and salmeterol monotherapies in symptomatic patients with COPD not receiving inhaled corticosteroids: the EMAX … F Maltais, L Bjermer, EM Kerwin, PW Jones, ML Watkins, L Tombs, ... Respiratory research 20, 1-15, 2019 | 114 | 2019 |
| A randomised trial of fluticasone furoate/vilanterol (50/25 μg; 100/25 μg) on lung function in COPD EM Kerwin, C Scott-Wilson, L Sanford, S Rennard, A Agusti, N Barnes, ... Respiratory medicine 107 (4), 560-569, 2013 | 110 | 2013 |
| Efficacy and safety of umeclidinium added to fluticasone furoate/vilanterol in chronic obstructive pulmonary disease: results of two randomized studies TM Siler, E Kerwin, AR Sousa, A Donald, R Ali, A Church Respiratory medicine 109 (9), 1155-1163, 2015 | 106 | 2015 |
| Safety and efficacy of the prostaglandin D2 receptor antagonist AMG 853 in asthmatic patients WW Busse, SE Wenzel, EO Meltzer, EM Kerwin, MC Liu, N Zhang, ... Journal of allergy and clinical immunology 131 (2), 339-345, 2013 | 94 | 2013 |
| Efficacy and safety of umeclidinium added to fluticasone propionate/salmeterol in patients with COPD: results of two randomized, double-blind studies TM Siler, E Kerwin, K Singletary, J Brooks, A Church COPD: Journal of Chronic Obstructive Pulmonary Disease 13 (1), 1-10, 2016 | 79 | 2016 |
| Once-daily ciclesonide improves lung function and is well tolerated by patients with mild-to-moderate persistent asthma DS Pearlman, WE Berger, E Kerwin, C LaForce, S Kundu, D Banerji Journal of allergy and clinical immunology 116 (6), 1206-1212, 2005 | 78 | 2005 |
| Long-term safety and efficacy of glycopyrrolate/formoterol metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with chronic obstructive pulmonary … NA Hanania, DP Tashkin, EM Kerwin, JF Donohue, M Denenberg, ... Respiratory medicine 126, 105-115, 2017 | 73 | 2017 |
